Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Link opens in a new tab
Search content at Hong Kong Baptist University
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Student theses
Datasets
Cell death induced by MPPa-PDT in prostate carcinoma in vitro and in vivo
Yuanyuan Tian
, Wingnang Leung
*
, Kevin K M YUE
, Nai Ki MAK
*
Corresponding author for this work
School of Chinese Medicine
Department of Biology
Research output
:
Contribution to journal
›
Journal article
›
peer-review
33
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cell death induced by MPPa-PDT in prostate carcinoma in vitro and in vivo'. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Adenocarcinoma
20%
Androgen-independent
20%
Apoptotic Cells
40%
Apoptotic Rate
20%
Caspase-3
20%
Caspase-3 Pathway
20%
Caspase-9
20%
Cell Cycle Progression
20%
Cell Death
100%
Chlorophyll a (Chl a)
20%
Curative Effect
20%
Cytotoxicity
20%
Dark Cytotoxicity
20%
Dose Effect
20%
Drug Dosing
20%
Extensive Application
20%
Flow Cytometer
20%
G1 Phase
20%
Histopathological Examination
40%
Human Umbilical Vein Endothelial Cells (HUVECs)
40%
In Vitro Study
20%
Light Dose
20%
Low Cytotoxicity
20%
Mode of Death
20%
MPPa
100%
MTT Reduction
20%
PC-3
20%
PC-3M
60%
PDTMP
100%
Photodynamic Therapy
40%
Photosensitizer
60%
Phototoxicity
40%
Poor Differentiation
20%
Prostate Cancer
20%
Prostate Carcinoma
100%
Tumor Growth
20%
Medicine and Dentistry
Adenocarcinoma
33%
Androgen
33%
Caspase 3
66%
Caspase 9
33%
Cell Cycle
33%
Cell Cycle Progression
33%
Cell Death
100%
Chlorophyll
33%
Cytotoxicity
100%
G1 Phase
33%
In Vitro
100%
PC-3M Cell Line
33%
Photochemotherapy
66%
Photocytotoxicity
66%
Photosensitizer
100%
Prostate Cancer
33%
Prostate Carcinoma
100%
Tumor Progression
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
33%
Androgen
33%
Caspase 3
66%
Caspase 9
33%
Chlorophyll
33%
Cytotoxicity
100%
Drug Dose
33%
Photodynamic Therapy
66%
Photosensitizer
100%
Prostate Cancer
33%
Prostate Carcinoma
100%
Tumor Growth
33%